Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress 2022-03-15 00:06
MediLink Therapeutics closes US$70 million Series B financing 2022-03-14 20:50
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine 2022-03-14 20:00
Guardant Health Receives Regulatory Approval for Guardant360 CDx in Japan 2022-03-14 16:22
Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making 2022-03-14 16:00
CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer 2022-03-14 08:05
Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea 2022-03-14 08:00
Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals 2022-03-11 21:38
NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC) 2022-03-11 21:07
Novavax Announces Launch of Global Vaccine Education Programs 2022-03-10 22:00
Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia 2022-03-10 12:00
Nature Research Custom Media: SHAPING THE FUTURE OF OMICS FOR ALL 2022-03-10 10:05
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-03-10 08:52
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress 2022-03-10 08:30
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting 2022-03-10 07:00
Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis 2022-03-10 00:57
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific 2022-03-09 21:57
NCCN Expands Resources for Treating Rare Cancer Types 2022-03-09 21:56
Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting 2022-03-09 20:00
1 150 151 152 153 154 415